Showing results (251-260 of 457) with videos related to

Sort By:
Pageof 46
European Journal of Cancer (Oxford, England : 1990)|November 16, 2021
Consistent survival benefit of enzalutamide plus androgen deprivation therapy in men with nonmetastatic castration-resistant prostate cancer: PROSPER subgroup analysis by age and regionUgo De Giorgi, Maha Hussain, Neal Shore, et al.
Urology|May 5, 2011
Once-daily dasatinib: expansion of phase II study evaluating safety and efficacy of dasatinib in patients with metastatic castration-resistant prostate cancerEvan Y Yu, Christophe Massard, Mitchell E Gross, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 12, 2018
Development and validation of a prognostic model for overall survival in chemotherapy-naïve men with metastatic castration-resistant prostate cancerA J Armstrong, P Lin, C S Higano, et al.
European Journal of Cancer (Oxford, England : 1990)|December 3, 2014
Assessing the impact of evolving evidence in renal cell carcinoma treatment: an update of the Renal Cell Carcinoma Appropriateness-based Treatment Toolkit (ReCATT)M E Gore, J Bellmunt, T Eisen, et al.
European Urology|March 12, 2014
Critical analysis of bladder sparing with trimodal therapy in muscle-invasive bladder cancer: a systematic reviewGuillaume Ploussard, Siamak Daneshmand, Jason A Efstathiou, et al.
Future Oncology (London, England)|October 12, 2021
Real-world outcomes of second novel hormonal therapy or radium-223 following first novel hormonal therapy for mCRPCOliver Sartor, Daniel George, Bertrand Tombal, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 19, 2015
Efficacy and safety of enzalutamide in patients 75 years or older with chemotherapy-naive metastatic castration-resistant prostate cancer: results from PREVAILJ N Graff, G Baciarello, A J Armstrong, et al.
ESMO Open|January 18, 2021
First-line treatment of metastatic clear cell renal cell carcinoma: a decision-making analysis among expertsS Aeppli, M Schmaus, T Eisen, et al.
Urology Practice|November 7, 2024
Evaluation of ChatGPT as a Reliable Source of Medical Information on Prostate Cancer for Patients: Global Comparative Survey of Medical Oncologists and UrologistsArnulf Stenzl, Andrew J Armstrong, Eamonn Rogers, et al.
The Oncologist|June 9, 2017
Current Clinical Practice Guidelines for the Treatment of Renal Cell Carcinoma: A Systematic Review and Critical EvaluationAristotle Bamias, Bernard Escudier, Cora N Sternberg, et al.
Pageof 46